Armenia vs Togo: Previously treated cases tested for RR-/MDR-TB
Armenia
100.0%
in 2024
Togo
100.0%
in 2024
Armenia rank
1st
Togo rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Armenia
- Togo
How they compare
Armenia currently reports 100.0% against 100.0% in Togo, a difference of 0.0%.
The two have swapped places 9 times across 17 shared years of data; in 2007 it was Armenia ahead.
Armenia ranks 1st and Togo ranks 1st of 180 countries.
Across the 3 decades both report, Armenia averaged higher in 2 and Togo in 1.
Head to head by decade
| Decade | Armenia | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 34.7% | 12.6% | 22.0% | Armenia |
| 2010s | 41.7% | 61.3% | 19.7% | Togo |
| 2020s | 98.4% | 92.2% | 6.2% | Armenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Armenia or Togo?
- Armenia, at 100.0% against 100.0% in Togo as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Armenia and Togo?
- 0.0%, with Armenia ahead.
- How many years of comparable data are there for Armenia and Togo?
- 17 years are reported by both, from 2007 to 2024.
- How do Armenia and Togo rank globally for previously treated cases tested for rr-/mdr-tb?
- Armenia ranks 1st and Togo ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.